Last Updated:
Tannishtha Chatterjee recently revealed that she has been diagnosed with Stage 4 oligometastatic cancer. Oncologists explain what this means.
Tannishtha Chatterjee has revealed she has been battling with stage 4 oligo metastatic cancer.
When actor and filmmaker Tannishtha Chatterjee, celebrated for her work in Hindi and English independent films, recently opened up about her health, it sparked an important conversation. In a heartfelt social media post, she revealed that she has been diagnosed with Stage 4 oligometastatic cancer and is currently undergoing treatment. Her words were not just about illness, but about resilience, friendship, and the extraordinary love she has found in those around her.
Her story brings focus to a medical condition that many patients fear, but few fully understand: oligometastatic cancer – a form of cancer that, despite being Stage 4, offers new possibilities for treatment and survival.
Understanding Oligometastatic Cancer
Cancer staging often determines how doctors approach treatment and what patients can expect. “In oncology, the outcome of cancer largely depends on the spread, or the stage, as we commonly say,” explains Dr. Sachin Sekhar Biswal, Medical Oncologist, Manipal Hospital Bhubaneshwar.
Metastasis refers to the spread of cancer from its original site to other organs. Oligometastatic cancer is a stage where the cancer has spread, but only to a limited number of sites: often fewer than five. Unlike widespread Stage 4 disease, these cases still allow doctors to consider curative or long-term control strategies.
Why Stage 4 Doesn’t Always Mean the End
“People often hear the words ‘Stage 4 cancer’ and feel like it’s the end of hope,” says Dr. Shekhar Salkar, Senior Consultant – Surgical Oncology, Manipal Hospital, Goa. “But advances in medicine are showing that not all Stage 4 cancers are the same. Oligometastatic cancer is one such condition where aggressive treatment can still be possible.”
For instance, if a patient has lung cancer that has spread to just one or two spots in the liver, doctors may treat those spots with surgery or targeted radiation, while continuing systemic therapy for the main cancer. This approach improves both survival rates and quality of life.
The Role of Modern Treatments
With advanced tools like Next-Generation Sequencing (NGS), oncologists can now study the genetic behaviour of tumours more precisely. “Recently, oligometastatic cancers are increasingly being treated with a personalised approach with multidisciplinary board reviews,” notes Dr. Biswal. “Some patients even proceed to curative treatments when the disease responds well,” he added.
Immunotherapy, targeted therapy, and high-quality chemotherapy are changing outcomes, making remission or long-term management possible in ways once unimaginable.
- Location :
Delhi, India, India
